Efficacy and safety of bevacizumab-based therapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer in the phase III BO17704 study (AVAiL)

Journal of Thoracic Oncology

Volumn 5, Issue 12, 2010, Pages 1970-1976

  Leighl, Natasha B ^a   Zatloukal, Petr ^b   Mezger, Jörg ^c   Ramlau, Rodryg ^d   Moore, Nicola ^e   Reck, Martin ^f   Manegold, Christian ^g  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^c St Vincentius Kliniken   (Germany)

^d GREATER POLAND CANCER CENTRE   (Poland)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

^f KRANKENHAUS GROSSHANSDORF   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bevacizumab; Elderly; Non small cell lung cancer; Safety

Indexed keywords

ANTIASTHMATIC AGENT; BENZODIAZEPINE DERIVATIVE; BEVACIZUMAB; BRONCHODILATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CISPLATIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GEMCITABINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NARCOTIC ANALGESIC AGENT; PLACEBO; PROTON PUMP INHIBITOR;

ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; BLEEDING; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PAIN; CANCER PATIENT; CANCER RECURRENCE; CAUCASIAN; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CROSSOVER PROCEDURE; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HAZARD RATIO; HEMOPTYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VENOUS THROMBOEMBOLISM; VOMITING;

EID: 78650515286     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181f49c22     Document Type: Article

References (21)

1. Bunn PA, Lilenbaum R. Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 2003;95:341-343. (Pubitemid 36395248)
2. Gridelli C. Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer? Lung Cancer 2002; 38(Suppl 2):S45-S50. (Pubitemid 35300449)
3. Earle CC, Venditti LN, Neumann PJ, et al. Who gets chemotherapy for metastatic lung cancer? Chest 2000;117:1239-1246. (Pubitemid 30321574)
4. Gridelli C, Langer C, Maione P, et al. Lung cancer in the elderly. J Clin Oncol 2007;25:1898-1907. (Pubitemid 46854424)
5. Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 2005;23:3112-3124. (Pubitemid 46224135)
6. Siu LL. Clinical trials in the elderly-a concept comes of age. N Engl J Med 2007;356:1575-1576.
7. Costa GJ, Fernandes AL, Pereira JR, et al. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC). Lung Cancer 2006;53:171-176.
8. Pallis AG, Polyzos A, Boukovinas, et al. Pooled analysis of elderly patients with non-small cell lung cancer treated with front line docetaxel/ gemcitabine regimen: the Hellenic Oncology Research Group experience. J Thorac Oncol 2008;3:505-510. (Pubitemid 351630278)
9. Pepe C, Hasan B, Winton TL, et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 2007;25:1553-1561. (Pubitemid 46733082)
10. Früh M, Rolland E, Pignon JP, et al. Pooled analysis of the effect of age on adjuvant cisplatin-based chemotherapy for completely resected nonsmall- cell lung cancer. J Clin Oncol 2008;26:3573-3581.
11. Gridelli C, Perrone F, Gallo C, et al. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 2003;95:362-372. (Pubitemid 36395256)
12. Gridelli C, De Maio E, Barbera S, et al. The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients. Lung Cancer 2008; 61:67-72. (Pubitemid 351862324)
13. Boukovinas I, Souglakos J, Hatzidaki D, et al. Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: a multicenter phase II study. Lung Cancer 2009;63:77-82.
14. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006;355: 2542-2550. (Pubitemid 44917502)
15. Reck M, von Pawel J, Zatloukal P, et al. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAiL. J Clin Oncol 2009; 27:1227-1234.
16. Ramalingam SS, Dahlberg SE, Langer CJ, et al. Outcomes for elderly, advanced-stage non small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol 2008; 26:60-65.
17. Townsley CA, Pond GR, Oza AM, et al. Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination. Clin Cancer Res 2006;12:2141-2149.
18. Therasse P, Eisenhauer EA, Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006;42:1031-1039.
19. Reck M, von Pawel J, Zatloukal P, et al. Overall survival with cisplatin- gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomized phase III trial (AVAiL). Ann Oncol 2010 Feb 11 [Epub ahead of print].
20. Garrido, P, Thatcher N, Crinò L, et al. Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390). Eur J Cancer Suppl 2009;7:557.
21. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000;36:1741-1745. (Pubitemid 30639493)